Staff report
The global contrast media market size was estimated at $7.31 billion in 2025 and is projected to reach $13.86 billion by 2033, growing at a CAGR of 8.39% from 2026 to 2033, according to a report from Grand View Research, a market research and consulting company.
The demand for contrast media is rising owing to the growing need for medical imaging and the rising burden of chronic disorders, the report states.
“High volume of imaging procedures, such as ultrasound and MRI scans, is anticipated to support the market growth,” the report states. “The growing global demand for medical imaging is a key factor driving the expansion of the contrast media market. Medical imaging plays a crucial role in the early detection, accurate diagnosis, and effective treatment planning of various health conditions. Millions of patients undergo diagnostic procedures such as MRI, CT scans, and X-rays every year.”
According to a study published by the National Library of Medicine in October 2023, approximately 40 million MRI scans are performed annually in the U.S. alone. An expected increase in the volume of imaging procedures worldwide is expected to significantly boost the demand for contrast media, essential for enhancing the visualization of internal body structures during these examinations.
In addition, the report highlighted key market trends and insights, including:
North America dominated the contrast media market with the largest revenue share of 38.92% in 2025.
By modality, the X-ray/CT segment led the market with the largest revenue share in 2025.
Based on product, the microbubble contrast media segment is anticipated to grow fastest over the forecast period.
Based on end use, the hospitals segment led the market with the largest revenue share in 2025.
By application, the neurological disorder segment led the market with the largest revenue share in 2025.
Based on route of administration, the intravenous segment is anticipated to grow fastest over the forecast period.
Fortune Business Insights reports that the global contrast media injectors market size was valued at $2.33 billion in 2025. The market is projected to grow from $2.59 billion in 2026 to $5.97 billion by 2034, exhibiting a CAGR of 11.01% during the forecast period.
The report also stated that increased diagnostic imaging will fuel market growth.
“The contrast media injectors market is a vital segment within diagnostic imaging equipment, supporting accurate and controlled delivery of contrast agents during imaging procedures such as computed tomography, magnetic resonance imaging and angiography,” the report said. “These systems are designed to ensure precise flow rates, timing, and pressure control, which are essential for high-quality diagnostic outcomes. Contrast media injectors market analysis highlights increasing dependence on advanced imaging techniques for early disease detection, interventional procedures and chronic condition management. Hospitals and diagnostic centers rely on injector systems to improve workflow efficiency, patient safety, and image consistency. The market is characterized by continuous technological improvements focused on automation, dose accuracy and integration with imaging modalities, reinforcing the clinical importance of contrast media injectors across modern diagnostic environments.”
The report adds that the contrast media injectors market in the United States is driven by high imaging procedure volumes, advanced healthcare infrastructure and widespread adoption of sophisticated diagnostic technologies.
“Healthcare facilities in the United States prioritize injector systems that enhance patient safety, reduce contrast waste and support high-throughput imaging workflows,” it reads. “Contrast media injectors market insights indicate strong demand from hospitals, outpatient imaging centers and specialized diagnostic clinics. The U.S. market emphasizes technologically advanced injector platforms with user-friendly interfaces and safety monitoring features. Continuous upgrades of imaging departments and focus on operational efficiency support steady utilization of contrast media injectors across the United States healthcare system.”
The April 2026 report also states that one trend identified in the contrast media injectors market analysis is a growing preference for dual-head and syringeless injector technologies.
Dual-head injectors support complex imaging procedures by allowing saline flushing alongside contrast delivery, improving image clarity and reducing contrast usage. Syringeless injectors are gaining attention due to reduced setup time, lower waste and enhanced infection control.
